Related references
Note: Only part of the references are listed.BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis
H. Teoh et al.
GENE THERAPY (2013)
CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
Eun-Hee Kim et al.
CANCER PREVENTION RESEARCH (2012)
BRCA1, Hormone, and Tissue-Specific Tumor Suppression
Yanfen Hu
International Journal of Biological Sciences (2012)
BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair
Samuel F. Bunting et al.
MOLECULAR CELL (2012)
Insights into the targeted elimination of BRCA1-defective cancer stem cells
Veena Somasundaram et al.
MEDICINAL RESEARCH REVIEWS (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Breast cancer statistics, 2011
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Rinske Drost et al.
CANCER CELL (2011)
CDDO-Imidazolide Induces DNA Damage, G2/M Arrest and Apoptosis in BRCA1-Mutated Breast Cancer Cells
Eun-Hee Kim et al.
CANCER PREVENTION RESEARCH (2011)
BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity
Reena Shakya et al.
SCIENCE (2011)
Targeting Triple-Negative Breast Cancer: The Lessons Learned From BRCA1-Associated Breast Cancers
Rita Nanda
SEMINARS IN ONCOLOGY (2011)
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
Laura N. Burga et al.
BREAST CANCER RESEARCH (2011)
Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan
Serge A. L. Zander et al.
CANCER RESEARCH (2010)
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Samuel F. Bunting et al.
CELL (2010)
Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling
Ines Barone et al.
CLINICAL CANCER RESEARCH (2010)
BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-alpha
Yongxian Ma et al.
MOLECULAR ENDOCRINOLOGY (2010)
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Preclinical mouse models for BRCA1-associated breast cancer
R. M. Drost et al.
BRITISH JOURNAL OF CANCER (2009)
Impaired Skin and Mammary Gland Development and Increased γ-Irradiation-Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1
Sang Soo Kim et al.
CANCER RESEARCH (2009)
Brca1 is required for embryonic development of the mouse cerebral cortex to normal size by preventing apoptosis of early neural progenitors
Jeremy N. Pulvers et al.
DEVELOPMENT (2009)
Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
Suhwan Chang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
A Selective Requirement for 53BP1 in the Biological Response to Genomic Instability Induced by Brca1 Deficiency
Liu Cao et al.
MOLECULAR CELL (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
Bridget A. Quinn et al.
PLOS ONE (2009)
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors
Norazizah Shafee et al.
CANCER RESEARCH (2008)
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Rui-Hong Wang et al.
MOLECULAR CELL (2008)
The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression
Reena Shakya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer
L. P. Jones et al.
ONCOGENE (2008)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation
W. Li et al.
ONCOGENE (2007)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach
Liu Cao et al.
CARCINOGENESIS (2007)
A mouse model of basal-like breast carcinoma with metaplastic elements
A. McCarthy et al.
JOURNAL OF PATHOLOGY (2007)
Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe
Y. Tominaga et al.
CELL DEATH AND DIFFERENTIATION (2007)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Δ11 isoform
Sang Soo Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency
Liu Cao et al.
EMBO JOURNAL (2006)
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
CX Deng
NUCLEIC ACIDS RESEARCH (2006)
The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells
YX Ma et al.
MOLECULAR ENDOCRINOLOGY (2006)
Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression
YF Hu et al.
ONCOGENE (2005)
The role of the BRCA1 tumor suppressor in DNA double-strand break repair
JR Zhang et al.
MOLECULAR CANCER RESEARCH (2005)
Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer
A Gadducci et al.
GYNECOLOGICAL ENDOCRINOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells
R Chodankar et al.
CURRENT BIOLOGY (2005)
Familial non-BRCA1/BRCA2-associated breast cancer
DM Eccles et al.
LANCET ONCOLOGY (2005)
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer:: The influence of age, grade, and histological type
WD Foulkes et al.
CLINICAL CANCER RESEARCH (2004)
Identification of BRCA1-IRIS, a BRCA1 locus product
WM ElShamy et al.
NATURE CELL BIOLOGY (2004)
Phosphorylation of estrogen receptor a blocks its acetylation and regulates estrogen sensitivity
Y Cui et al.
CANCER RESEARCH (2004)
BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation
JMA Turner et al.
CURRENT BIOLOGY (2004)
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
RH Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents
HE Bryant et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Estrogen receptor mutations in human disease
MH Herynk et al.
ENDOCRINE REVIEWS (2004)
Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations:: A critical review of the literature
R Calderon-Margalit et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
BRCA1 functions as a breast stem cell regulator
WD Foulkes
JOURNAL OF MEDICAL GENETICS (2004)
Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1
SS Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Aberrant splicing induced by missense mutations in BRCA1:: clues from a humanized mouse model
YP Yang et al.
HUMAN MOLECULAR GENETICS (2003)
Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues
TR Berton et al.
ONCOGENE (2003)
Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice
XL Xu et al.
DEVELOPMENT (2003)
Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control
ZK Lou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Roles of BRCA1 in DNA damage repair: a link between development and cancer
CX Deng et al.
HUMAN MOLECULAR GENETICS (2003)
Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice
R Bachelier et al.
ONCOGENE (2003)
Senescence aging, and malignant transformation mediated by p53 in mice lacking the Brcal full-length isoform
L Cao et al.
GENES & DEVELOPMENT (2003)
Roles of BRCA1 in centrosome duplication
CX Deng
ONCOGENE (2002)
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer
Z Weaver et al.
ONCOGENE (2002)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Tumor formation in Brca1 conditional mutant mice
CX Deng
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2002)
The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients
SJ Elledge et al.
CANCER CELL (2002)
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
L Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
XL Xu et al.
NATURE GENETICS (2001)
Tumorigenesis in mice carrying a truncating Brca1 mutation
T Ludwig et al.
GENES & DEVELOPMENT (2001)
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage
P Hohenstein et al.
ONCOGENE (2001)
Direct removal in the mouse of a flexed neo gene from a three-loxP conditional knockout allele by two novel approaches
XL Xu et al.
GENESIS (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
BracI required for T cell linage development but not TCR loci rearrangement
TW Mak et al.
NATURE IMMUNOLOGY (2000)
Share Paper
